Data / Form D filings / GelSana Therapeutics, Inc.
GelSana Therapeutics, Inc.: Form D filing
GelSana Therapeutics, Inc., a biotechnology company in Aurora, CO, filed a Form D with the SEC in 2026. The latest, on October 8, 2026, reports $4.4 million sold of a $4.9 million offering to 33 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12635 E MONTVIEW BLVD STE 326, Aurora, CO, 80045
- Phone
- (216) 502-0901
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2002665
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 8 | Amendment | $4,931,726 | $4,352,701 | $579,025 | 33 | Nov 20 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Melissa Krebs | Executive Officer, Director | |
| Mike Freeman | Director | |
| Diana Verrilli | Director |
Other biotechnology companies in Colorado that filed recently
- Renovare Therapeutics, Inc. $100,000 · Oct 2
Every Form D from the week of Oct 5 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what GelSana Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.